KEY PRODUCTS
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
01 1RIVASTIGMINE HYDROGEN TARTRATE
01 1India
01 1Active
01 1Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17249
Submission : 2004-03-19
Status : Active
Type : II
20
Dr Reddys Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is RIVASTIGMINE HYDROGEN TARTRATE, with a corresponding US DMF Number 17249.
Remarkably, this DMF maintains an Active status since its submission on March 19, 2004, highlighting commitment to regulatory compliance.
